The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients

Amy Lewis; Carla Felice; Tomoko Kumagai; Cecilia Lai; Kriti Singh; Rosemary R. Jeffery; Roger Feakins; Eleni Giannoulatou; Alessandro Armuzzi; Noor Jawad; James O. Lindsay; Andrew Silver

doi:10.1371/journal.pone.0173664

Loading metrics

Open Access

Peer-reviewed

Research Article

The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients

Amy Lewis,

Affiliation Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine & Dentistry, London E1 2AT United Kingdom
⨯
Carla Felice,

Affiliations Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine & Dentistry, London E1 2AT United Kingdom, IBD Unit, Complesso Integrato Columbus, Gemelli Hospital Catholic University Foundation, Rome, Italy
⨯
Tomoko Kumagai,

Affiliation Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine & Dentistry, London E1 2AT United Kingdom
⨯
Cecilia Lai,

Affiliation Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine & Dentistry, London E1 2AT United Kingdom
⨯
Kriti Singh,

Affiliation Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine & Dentistry, London E1 2AT United Kingdom
⨯
Rosemary R. Jeffery,

Affiliation Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine & Dentistry, London E1 2AT United Kingdom
⨯
Roger Feakins,

Affiliation Department of Histopathology, The Royal London Hospital, London, E1 1BB United Kingdom
⨯
Eleni Giannoulatou,

Affiliations Victor Chang Cardiac Research Institute, Darlinghurst, New South Wales, Australia, The University of New South Wales, Sydney, New South Wales, Australia
⨯
Alessandro Armuzzi,

Affiliation IBD Unit, Complesso Integrato Columbus, Gemelli Hospital Catholic University Foundation, Rome, Italy
⨯
Noor Jawad,

Affiliation Barts Cancer Institute, Barts and The London School of Medicine & Dentistry, London EC1M 6BQ United Kingdom
⨯
James O. Lindsay ,

* E-mail: a.silver@qmul.ac.uk (AS); james.lindsay@bartshealth.nhs.uk (JOL)

Affiliation Centre for Immunobiology, Blizard Institute, Barts and The London School of Medicine & Dentistry, London E1 2AT United Kingdom
⨯
Andrew Silver

* E-mail: a.silver@qmul.ac.uk (AS); james.lindsay@bartshealth.nhs.uk (JOL)

Affiliation Centre for Genomics and Child Health, Blizard Institute, Barts and The London School of Medicine & Dentistry, London E1 2AT United Kingdom

http://orcid.org/0000-0002-8263-5733

⨯

The miR-200 family is increased in dysplastic lesions in ulcerative colitis patients

Amy Lewis,
Carla Felice,
Tomoko Kumagai,
Cecilia Lai,
Kriti Singh,
Rosemary R. Jeffery,
Roger Feakins,
Eleni Giannoulatou,
Alessandro Armuzzi,
Noor Jawad

Published: March 13, 2017
https://doi.org/10.1371/journal.pone.0173664

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

MicroRNAs
Is the Subject Area "MicroRNAs" applicable to this article?

Thanks for your feedback.
Dysplasia
Is the Subject Area "Dysplasia" applicable to this article?

Thanks for your feedback.
Ulcerative colitis
Is the Subject Area "Ulcerative colitis" applicable to this article?

Thanks for your feedback.
Colorectal cancer
Is the Subject Area "Colorectal cancer" applicable to this article?

Thanks for your feedback.
Biopsy
Is the Subject Area "Biopsy" applicable to this article?

Thanks for your feedback.
Lesions
Is the Subject Area "Lesions" applicable to this article?

Thanks for your feedback.
Inflammatory bowel disease
Is the Subject Area "Inflammatory bowel disease" applicable to this article?

Thanks for your feedback.
Inflammation
Is the Subject Area "Inflammation" applicable to this article?

Thanks for your feedback.